Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Steroid vitronectin receptor ligands discovered during joint research program

Oct. 9, 2000

Potent and selective EP2 receptor agonist with bone anabolic effects presented at ASBMR

Oct. 9, 2000

Wyeth-Ayerst presents new SERM with potentially improved therapeutic profile

Oct. 9, 2000

LY-510929: Ligand's new drug candidate for diabetes and obesity

Oct. 9, 2000

AMG-073 normalizes total serum calcium in hyperparathyroidism

Oct. 9, 2000

Cellegy's Rx for sexual dysfunction in women completes phase I/II

Oct. 9, 2000

ASBMR news: potent new cathepsin K inhibitor from SB prevents bone loss in ovariectomized rats

Oct. 6, 2000

HEP-187, a new vitamin D analogue with a promising profile for metabolic bone diseases

Oct. 6, 2000

Novel tricyclic compounds from Dr. Reddy useful for hyperglycemia, hyperlipidemia, etc.

Oct. 6, 2000

Oral alphavbeta3 antagonist L-806978 inhibits bone loss in vivo

Oct. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
EASL spotlight: TUNE-401 advances epigenetic silencing in HBV
BioWorld
Several presentations at EASL highlight a new generation of therapies coming into view, with the work from Tune Therapeutics Inc. standing out as one of the most...